NO20043101L - Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet - Google Patents
Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighetInfo
- Publication number
- NO20043101L NO20043101L NO20043101A NO20043101A NO20043101L NO 20043101 L NO20043101 L NO 20043101L NO 20043101 A NO20043101 A NO 20043101A NO 20043101 A NO20043101 A NO 20043101A NO 20043101 L NO20043101 L NO 20043101L
- Authority
- NO
- Norway
- Prior art keywords
- orally active
- enhanced bioavailability
- taxane derivatives
- pharmaceutical mixtures
- active taxane
- Prior art date
Links
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34288901P | 2001-12-20 | 2001-12-20 | |
| PCT/US2002/040127 WO2003053350A2 (en) | 2001-12-20 | 2002-12-12 | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043101L true NO20043101L (no) | 2004-07-19 |
Family
ID=23343716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043101A NO20043101L (no) | 2001-12-20 | 2004-07-19 | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030220391A1 (de) |
| EP (1) | EP1465618A2 (de) |
| JP (1) | JP2006501134A (de) |
| KR (1) | KR20040066921A (de) |
| CN (1) | CN1273130C (de) |
| AR (1) | AR037951A1 (de) |
| AU (1) | AU2002361701A1 (de) |
| BR (1) | BR0215184A (de) |
| CA (1) | CA2470826A1 (de) |
| GE (1) | GEP20063806B (de) |
| HR (1) | HRP20040545A2 (de) |
| HU (1) | HUP0500843A2 (de) |
| IL (1) | IL162118A0 (de) |
| IS (1) | IS7306A (de) |
| MX (1) | MXPA04005877A (de) |
| NO (1) | NO20043101L (de) |
| PE (1) | PE20030742A1 (de) |
| PL (1) | PL374283A1 (de) |
| RS (1) | RS52904A (de) |
| RU (1) | RU2004119557A (de) |
| TW (1) | TW200302086A (de) |
| UY (1) | UY27598A1 (de) |
| WO (1) | WO2003053350A2 (de) |
| ZA (1) | ZA200404584B (de) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005519075A (ja) * | 2002-02-25 | 2005-06-30 | リフジャスロウン エイチエフ | 吸収促進剤 |
| US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| KR100533458B1 (ko) * | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | 파클리탁셀의 가용화용 조성물 및 그의 제조 방법 |
| EP1498120A1 (de) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Halbfeste Formulierung für die orale Verabreichung des Taxols |
| AU2004275881A1 (en) | 2003-09-25 | 2005-04-07 | Tapestry Pharmaceuticals, Inc. | 9,10-alpha,alpha-OH-taxane analogs and methods for production thereof |
| US20060088591A1 (en) * | 2004-10-22 | 2006-04-27 | Jinghua Yuan | Tablets from a poorly compressible substance |
| WO2006058121A1 (en) * | 2004-11-23 | 2006-06-01 | Bristol-Myers Squibb Company | Crystalline forms of 3'-tert-butyl-3'-n-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-n-debenzoyl-4-o-methoxycarbonyl-paclitaxel |
| EP3345631A1 (de) * | 2005-02-18 | 2018-07-11 | Abraxis BioScience, LLC | Arzneimittel mit verbesserter hydrophobie zur einarbeitung in medizinische vorrichtungen |
| AU2012202903B2 (en) * | 2005-02-18 | 2014-12-11 | Abraxis Bioscience, Inc. | Drugs with improved hydrophobicity for incorporation in medical devices |
| PL2233156T3 (pl) | 2005-07-15 | 2013-09-30 | Angiochem Inc | Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych |
| US20070015834A1 (en) * | 2005-07-18 | 2007-01-18 | Moshe Flashner-Barak | Formulations of fenofibrate containing PEG/Poloxamer |
| US7771751B2 (en) | 2005-08-31 | 2010-08-10 | Abraxis Bioscience, Llc | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| WO2007134354A1 (de) * | 2006-05-23 | 2007-11-29 | Ebewe Pharma Ges.M.B.H. Nfg. Kg | Pharmazeutische formulierung |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| EP1946747A1 (de) * | 2007-01-17 | 2008-07-23 | Sandoz AG | Taxanderivat enthaltende pharmazeutische Zusammensetzung von verbesserter Stabilität |
| WO2008109360A1 (en) * | 2007-02-28 | 2008-09-12 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| KR101544498B1 (ko) * | 2007-08-24 | 2015-08-17 | 스티칭 허트 네덜란드 칸커 인스티튜트 | 종양성 질환의 치료를 위한 조성물 |
| US9089544B2 (en) * | 2007-08-24 | 2015-07-28 | Slotervaart Participaties Bv | Composition |
| EP2316422A1 (de) * | 2007-11-12 | 2011-05-04 | Novartis AG | Flüssige Zubereitungen enthaltend Valsartan |
| EP2077132A1 (de) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung |
| ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
| WO2010043047A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Conjugates of glp-1 agonists and uses thereof |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| EP2432531B1 (de) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
| CN102038635A (zh) | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| MX2012005961A (es) | 2009-11-25 | 2012-06-14 | Boehringer Ingelheim Int | Nebulizador. |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2585151B1 (de) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Vernebler |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| EP2777691A1 (de) * | 2013-03-14 | 2014-09-17 | Pharmachemie B.V. | Taxoid - Reinigung der flüssigen Hilfsstoffen |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2835146B1 (de) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Zerstäuber |
| HUE058904T2 (hu) | 2014-05-07 | 2022-09-28 | Boehringer Ingelheim Int | Porlasztókészülék |
| US10722666B2 (en) | 2014-05-07 | 2020-07-28 | Boehringer Ingelheim International Gmbh | Nebulizer with axially movable and lockable container and indicator |
| CA2948071C (en) | 2014-05-07 | 2022-08-30 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
| CN103980232A (zh) * | 2014-06-05 | 2014-08-13 | 北京诺普德医药科技有限公司 | 10-乙酰基多西紫杉醇及其用途 |
| EP3307326B9 (de) | 2015-06-15 | 2021-02-24 | Angiochem Inc. | Verfahren zur behandlung von leptomeningealer karzinomatose |
| TWI715636B (zh) * | 2015-09-30 | 2021-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| CN108066335B (zh) * | 2016-11-11 | 2020-02-21 | 北京康辰药业股份有限公司 | 一种含有紫杉醇或其类似物的药物组合物及其制备方法 |
| FR3113238B1 (fr) | 2020-08-05 | 2024-04-05 | Gattefosse Sas | Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5817321A (en) * | 1992-10-08 | 1998-10-06 | Supratek Pharma, Inc. | Biological agent compositions |
| CA2149150C (en) * | 1992-11-27 | 2000-08-01 | David R. Carver | Injectable taxol composition with improved stability |
| US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| US6395770B1 (en) * | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| PL189698B1 (pl) * | 1996-03-12 | 2005-09-30 | Pg Txl Co | Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania |
| US5756537A (en) * | 1996-11-08 | 1998-05-26 | Parkash S. Gill, M.D., Inc. | Regime for paclitaxel in Kaposi's sarcoma patients |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US5980936A (en) * | 1997-08-07 | 1999-11-09 | Alliance Pharmaceutical Corp. | Multiple emulsions comprising a hydrophobic continuous phase |
| EP1067923A4 (de) * | 1997-12-31 | 2002-11-13 | Bristol Myers Squibb Co | 2-aroyl-4-acyl paclitaxel (taxol) analoge |
| IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
| US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| ATE256117T1 (de) * | 1999-05-17 | 2003-12-15 | Bristol Myers Squibb Co | Neue umsetzungsbedingungen für die spaltung von silylethern bei der herstellung von paclitaxel (taxol(r)) und paclitaxel -analogen |
| AU769858B2 (en) * | 1999-08-11 | 2004-02-05 | Bristol-Myers Squibb Company | Process for the preparation of a paclitaxel C-4 methyl carbonate analog |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| US6916942B2 (en) * | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
| US6750246B1 (en) * | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| TWI310684B (en) * | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
| JP2004536026A (ja) * | 2000-11-28 | 2004-12-02 | トランスフォーム ファーマシューティカルズ，インコーポレーティッド． | パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤 |
| TWI297335B (en) * | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
-
2002
- 2002-12-12 EP EP02797339A patent/EP1465618A2/de not_active Withdrawn
- 2002-12-12 KR KR10-2004-7009593A patent/KR20040066921A/ko not_active Withdrawn
- 2002-12-12 RU RU2004119557/15A patent/RU2004119557A/ru not_active Application Discontinuation
- 2002-12-12 BR BRPI0215184-7A patent/BR0215184A/pt not_active IP Right Cessation
- 2002-12-12 IL IL16211802A patent/IL162118A0/xx unknown
- 2002-12-12 GE GE5614A patent/GEP20063806B/en unknown
- 2002-12-12 HU HU0500843A patent/HUP0500843A2/hu unknown
- 2002-12-12 HR HR20040545A patent/HRP20040545A2/xx not_active Application Discontinuation
- 2002-12-12 RS YU52904A patent/RS52904A/sr unknown
- 2002-12-12 WO PCT/US2002/040127 patent/WO2003053350A2/en not_active Ceased
- 2002-12-12 JP JP2003554110A patent/JP2006501134A/ja not_active Withdrawn
- 2002-12-12 PL PL02374283A patent/PL374283A1/xx not_active Application Discontinuation
- 2002-12-12 AU AU2002361701A patent/AU2002361701A1/en not_active Abandoned
- 2002-12-12 CN CNB028254708A patent/CN1273130C/zh not_active Expired - Fee Related
- 2002-12-12 CA CA002470826A patent/CA2470826A1/en not_active Abandoned
- 2002-12-16 TW TW091136275A patent/TW200302086A/zh unknown
- 2002-12-19 AR ARP020105039A patent/AR037951A1/es unknown
- 2002-12-19 US US10/323,551 patent/US20030220391A1/en not_active Abandoned
- 2002-12-20 UY UY27598A patent/UY27598A1/es not_active Application Discontinuation
-
2003
- 2003-01-06 PE PE2003000013A patent/PE20030742A1/es not_active Application Discontinuation
-
2004
- 2004-06-09 ZA ZA200404584A patent/ZA200404584B/en unknown
- 2004-06-10 IS IS7306A patent/IS7306A/is unknown
- 2004-06-16 MX MXPA04005877A patent/MXPA04005877A/es unknown
- 2004-07-19 NO NO20043101A patent/NO20043101L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR037951A1 (es) | 2004-12-22 |
| MXPA04005877A (es) | 2004-09-13 |
| WO2003053350A2 (en) | 2003-07-03 |
| CA2470826A1 (en) | 2003-07-03 |
| EP1465618A2 (de) | 2004-10-13 |
| BR0215184A (pt) | 2006-06-06 |
| JP2006501134A (ja) | 2006-01-12 |
| PL374283A1 (en) | 2005-10-03 |
| CN1606437A (zh) | 2005-04-13 |
| IL162118A0 (en) | 2005-11-20 |
| KR20040066921A (ko) | 2004-07-27 |
| ZA200404584B (en) | 2005-09-13 |
| PE20030742A1 (es) | 2003-09-02 |
| RU2004119557A (ru) | 2005-04-20 |
| AU2002361701A1 (en) | 2003-07-09 |
| RS52904A (sr) | 2006-12-15 |
| GEP20063806B (en) | 2006-04-25 |
| TW200302086A (en) | 2003-08-01 |
| WO2003053350A3 (en) | 2004-01-15 |
| CN1273130C (zh) | 2006-09-06 |
| UY27598A1 (es) | 2003-07-31 |
| HUP0500843A2 (hu) | 2005-12-28 |
| IS7306A (is) | 2004-06-10 |
| HRP20040545A2 (en) | 2005-08-31 |
| US20030220391A1 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04005877A (es) | Composiciones farmaceuticas de derivados de taxano oralmente activos con biodisponibilidad mejorada. | |
| CY1115386T1 (el) | Συνδυασμος αζελαστινης και μομεταζονης | |
| NO2016005I1 (no) | 2-okso-1-pyrrolidinderivater, farmasøytisk preparat og deres anvendelse for fremstilling av et medikament | |
| LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
| NO20075660L (no) | Blanding for behandling av inflammatoriske sykdommer | |
| NO2012006I2 (no) | Telaprevir og enhver terapeutisk ekvivalent form derav som er beskyttet av basispatentet, slik som farmasøytisk akseptable salter og/eller solvater av telaprevir eller solvater av slike salter | |
| NO20035438L (no) | Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| CO5590918A2 (es) | Formulaciones | |
| DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
| CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
| EP1574215A4 (de) | Feste arznei zur oralen verabreichung | |
| NO20021050L (no) | Nye derivater av flavoner, xantoner og kumariner | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| DK1992338T3 (da) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
| DK1379508T3 (da) | N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf | |
| EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
| NO20061702L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en ostrogen agonist/antagonist | |
| NO20043314L (no) | Sedative non-benzodiazepinformuleringer | |
| NO20062668L (no) | Orale formuleringer av desoxypeganin og anvendelser derav | |
| WO2004062564A3 (en) | Sedative non-benzodiazepine formulations | |
| EA200602199A1 (ru) | Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство | |
| EE200300465A (et) | Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |